Four trials compared an LHRH agonist versus chemotherapy, and three other trials compared the combination of an LHRH agonist and tamoxifen versus chemotherapy
medication ivermectin 3mg Patients in the low risk group received anastrozole alone N 42, those in the moderate group were randomised to anastrozole plus risedronate 35 mg once a week N 77 or anastrozole plus placebo N 77 and those in the high risk group received anastrozole plus risedronate 35 mg once a week N 38